Other Industries
Comparing ESG Regulations in the U.S., the U.K., and the EU
Environmental, social, and corporate governance (ESG) is a rapidly evolving framework designed to hold companies accountable for their actions and increase understanding of how an organization or company manages its risks around these issues. In a perfect world, ESG knowledge would increase investor...
2023-04-06 11:26
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
Born and raised in Japan, Takashi “Tora” Toraishi has a master's degree and a Ph.D. from the University of Tokyo, in nuclear chemistry. Before he joined Rakuten Medical, Tora worked in the molecular biology and chemistry field. He acted as a partner for McKinsey & Company, providing management consu...
2023-04-06 11:24
2023 Trend Forecast: Transforming Healthcare with Real-world Data and Personalized Medicine
By the end of 2022, while the global COVID-19 pandemic seemed to be subsiding, the development of the biotech and healthcare industry has kept up its pace over the past three years. Rather, consolidation efforts have been accelerated in specific areas, especially the integration of healthcare and te...
2023-01-31 15:47
Rob Knight and Jing-Yuan Fu Elaborate On Microbiome Research Trends at the 7th Asia Microbiome Conference(AMC)
The Institute of Biological Chemistry (IBC), Academia Sinica, National Taiwan University Hospital (NTUH), and BIOTOOLS hosted the 7th annual Asia Microbiome Conference (AMC) on January 7th, 2023, at Academia Sinica, Taiwan. With over 400 hundred domestic and foreign microbiome experts participating ...
2023-01-31 15:38
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
Established in February 2020, Micronbrane Medical is a Taiwan-based biotechnology startup company dedicated to the development of precision medicine. With an international team of scientists, engineers and innovators, the company is focused on the development of clinical pathogen diagnostic a...
2022-12-08 10:15
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
PHILADELPHIA –RemeGenattended the American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2022, from Nov 10-14, to present promising phase III trial data for SLE which met its primary endpoint, and phase II trial data for primary Sjogren’s syndrome which showed encouraging sa...
2022-12-08 10:11